SCOPUS 정보 검색 플랫폼

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1841-1847

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

(5) Thompson, Andrew E a,c Shea, Beverley b Welch, Vivian a Fenlon, Deborah b Pope, Janet E b

a UNIVERSITY OF WESTERN ONTARIO (Canada)

b UNIVERSITY OF OTTAWA (Canada)

c ST JOSEPH S HEALTH CENTRE (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; ISCHEMIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SKIN TEMPERATURE; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; HUMANS; ILOPROST; INJECTIONS, INTRAVENOUS; ISCHEMIA; LOSARTAN; RANDOMIZED CONTROLLED TRIALS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SKIN TEMPERATURE; SKIN ULCER;

EID: 0034881398 PISSN: 00043591 EISSN: None Source Type: Journal
DOI: 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8 Document Type: Article

Times cited : (252)

References (40)

1
- 0000615973
- Connective tissue diseases characterized by fibrosis: Scleroderma
- Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Philadelphia: WB Saunders
- (1997) Textbook of rheumatology. 5th ed. , vol.2 , pp. 1133-1162
- Seibold, J.R.¹

2
- 0026714852
- Raynaud's phenomenon: A proposal for classification
- (1992) Clin Exp Rheumatol , vol.10 , pp. 485-488
- LeRoy, E.C.¹ Medsger T.A., Jr.²

3
- 84970861456
- Identifying relevant studies for systematic reviews
- (1994) BMJ , vol.309 , pp. 1286-1291
- Dickersin, K.¹ Scherer, R.² Lefebvre, C.³

4
- 0029914622
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
- (1996) Control Clin Trials , vol.17 , pp. 1-12
- Jadad, A.¹ Moore, A.² Carroll, D.³ Jenkinson, C.⁴ Reynolds, D.J.⁵ Gavaghan, D.J.⁶

5
- 0003577917
- Hillside (NJ): Lawrence Erlbaum Associates
- (1988) Statistical power analysis for the behavioural sciences
- Cohen, J.¹

6
- 0018887574
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)
- (1980) Arthritis Rheum , vol.23 , pp. 581-590

7
- 0003504721
- New York: Oxford University Press
- (1994) Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine
- Petitti, D.¹

8
- 85047675605
- Nifedipine in the treatment of Raynaud's syndrome
- (1986) Cardiovasc Res , vol.20 , pp. 466-470
- Aldoori, M.¹ Campbell, W.B.² Dieppe, P.A.³

9
- 0024551252
- Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon
- (1989) Angiology , vol.40 , pp. 114-121
- Codella, O.¹ Caramaschi, P.² Olivieri, O.³ Perbellini, L.⁴ Perbellini, A.⁵ Bambara, L.M.⁶

10
- 0023637159
- Slow release nifedipine in the treatment of Raynaud's phenomenon
- (1987) Int Angiol , vol.6 , pp. 359-363
- Constantini, A.¹ Martelli, E.² Bavera, P.³ Agus, G.B.⁴

11
- 0027096537
- Effetti della terapia a lungo termine con iloprost sul fenomeno di Raynaud nella sclerosi sistemica progressiva
- (1992) Minerva Medi , vol.83 , pp. 739-744
- Cordioli, F.¹ Virgilio, S.² Ghirardi, R.³ Martinelli, M.⁴

12
- 0021223458
- Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon
- (1984) Am Heart J , vol.108 , pp. 370-373
- Creager, M.A.¹ Pariser, K.M.² Winston, E.M.³ Rasmussen, H.M.⁴ Miller, K.B.⁵ Coffman, J.D.⁶

13
- 0022836899
- The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: A double blind crossover study
- (1986) Clin Rheumatol , vol.5 , pp. 493-498
- Finch, M.B.¹ Dawson, J.² Johnston, G.D.³

14
- 0024148984
- A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon
- (1988) Clin Rheumatol , vol.7 , pp. 359-365
- Finch, M.B.¹ Copeland, S.² Passmore, A.P.³ Johnston, G.D.⁴

15
- 0022516521
- Clinical and laboratory effects of nifedipine in Raynaud's phenomenon
- (1986) Rheumatol Int , vol.6 , pp. 85-88
- Hawkins, S.J.¹ Black, C.M.² Hall, N.D.³ McGregor, A.⁴ Ring, E.F.⁵ Maddison, P.J.⁶

16
- 0021959733
- A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon
- (1985) Ann Rheum Dis , vol.44 , pp. 30-33
- Kahan, A.¹ Amor, B.² Menkes, C.J.³

17
- 0021917427
- Nifedipine in the treatment of Raynaud's phenomenon: Evidence for inhibition of platelet activation
- (1985) Am J Med , vol.78 , pp. 602-608
- Malamet, R.¹ Wise, R.A.² Ettinger, W.H.³ Wigley, F.M.⁴

18
- 0021967917
- A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon
- (1985) J Rheumatol , vol.12 , pp. 724-727
- Rhedda, A.¹ McCans, J.² Willan, A.R.³ Ford, P.M.⁴

19
- 0023236792
- Nicardipine for the treatment of Raynaud's phenomena: A double blind crossover trial of a new calcium entry blocker
- (1987) J Rheumatol , vol.14 , pp. 745-750
- Rupp, P.A.¹ Mellinger, S.² Kohler, J.³ Dorsey, J.K.⁴ Furst, D.E.⁵

20
- 0021269427
- Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon: A controlled double blind trial
- (1984) J Rheumatol , vol.11 , pp. 362-364
- Sauza, J.¹ Kraus, A.² Gonsalez-Amaro, R.³ Alarcon-Segovia, D.⁴

21
- 0020466653
- Controlled trial of nifedipine in the treatment of Raynaud's phenomenon
- (1982) Lancet , vol.2 , pp. 1299-1301
- Smith, C.D.¹ McKendry, R.J.²

22
- 0022498638
- Clinical and rheological effects of nifedipine in Raynaud's phenomenon
- (1986) Br J Clin Pharmacol , vol.22 , pp. 449-454
- Waller, D.G.¹ Challenor, V.F.² Francis, D.A.³ Roath, O.S.⁴

23
- 0023236955
- Nicardipine in the treatment of Raynaud's phenomenon: Dissociation of platelet activation from vasospasm
- (1987) Arthritis Rheum , vol.30 , pp. 281-286
- Wigley, F.M.¹ Wise, R.A.² Malamet, R.³ Scott, T.E.⁴

24
- 0023187962
- Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: A double blind placebo controlled trial
- (1987) J Rheumatol , vol.14 , pp. 278-283
- Wise, P.A.¹ Malamet, R.² Wigley, F.M.³

25
- 0026348794
- Double-blind placebo-controlled cross-over study of oral nicardipine in the treatment of Raynaud's phenomenon
- (1991) J Cardiovasc Pharmacol , vol.18 , pp. 813-818
- Wolersheim, H.¹ Thien, T.²

26
- 0020083654
- Etude controlee de la nifedipine dans le treatment du phenomene de Raynaud
- (1982) Rev Rheum Mal Osteoartic , vol.49 , pp. 337-343
- Kahan, A.¹ Weber, S.² Amor, B.³ Saporta, L.⁴ Hodara, M.⁵ Degeorges, M.⁶

27
- 0022260222
- Nifedipine and Raynaud's phenomenon associated with connective tissue diseases
- (1985) Int Angiol , vol.4 , pp. 221-223
- Kahan, A.¹ Weber, S.² Amor, B.³ Menkes, C.J.⁴ Hodara, M.⁵ Degeorges, M.⁶

28
- 0023470381
- Nifedipine in primary Raynaud's phenomenon and in scleroderma: Oral versus sublingual hemodynamic effects
- (1987) J Clin Pharmacol , vol.27 , pp. 907-913
- Wollersheim, H.¹ Thien, T.² Van't Laar, A.³

29
- 0021237785
- Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon
- (1984) Am J Med , vol.77 , pp. 451-456
- Ettinger, W.H.¹ Wise, P.A.² Schaffhauser, R.N.³ Wigley, F.M.⁴

30
- 0020570468
- Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon)
- (1983) Eur Heart J , vol.4 , Issue.SUPPL. C , pp. 123-129
- Kahan, A.¹ Weber, S.² Amor, B.³ Menkes, C.J.⁴ Saporta, L.⁵ Hodara, M.⁶

31
- 0022007474
- Nifedipine and alpha-1-adrenergic blockade in Raynaud's phenomenon
- (1985) Eur Heart J , vol.6 , pp. 702-705
- Kahan, A.¹ Foult, J.M.² Weber, S.³ Amor, B.⁴ Menkes, C.J.⁵ Degeorges, M.⁶

32
- 0023181718
- Nicardipine in the treatment of Raynaud's phenomenon: A randomized double-blind trial
- (1987) Angiology , vol.38 , pp. 333-337
- Kahan, A.¹ Amor, B.² Menkes, C.J.³ Weber, S.⁴ Guerin, F.⁵ Degeorges, M.⁶

33
- 0024574059
- Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: A double blind randomized study
- (1989) BMJ , vol.298 , pp. 561-564
- Rademaker, M.¹ Cooke, E.D.² Almond, N.E.³ Beacham, J.A.⁴ Smith, R.E.⁵ Mant, T.G.⁶

34
- 0020957847
- Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon
- (1983) N Engl J Med , vol.308 , pp. 880-883
- Rodeheffer, R.J.¹ Rommer, J.A.² Wigley, F.³ Smith, C.R.⁴

35
- 0023236881
- Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis
- (1987) Br J Dermatol , vol.117 , pp. 237-241
- Thomas, M.R.H.¹ Rademaker, M.² Grimes, S.M.³ MacKay, A.⁴ Kovacs, I.B.⁵ Cook, E.D.⁶

36
- 0033511724
- Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial
- (1999) Arthritis Rheum , vol.42 , pp. 2646-2655
- Dziadzio, M.¹ Denton, C.P.² Smith, R.³ Howell, K.⁴ Blann, A.⁵ Bowers, E.⁶

37
- 0025317589
- Effects of low-dose nifedipine on a cold provocation test in people with Raynaud's disease
- (1990) J Cardiovasc Pharmacol , vol.15 , pp. 853-855
- Weber, A.¹ Bounameaux, H.²

38
- 0022879177
- Nifedipine in the treatment of idiopathic Raynaud's syndrome
- (1986) J Rheumatol , vol.13 , pp. 331-336
- Sarkozi, J.¹ Bookman, A.² Mahon, W.³ Ramsay, C.⁴ Detsky, A.S.⁵ Keystone, E.C.⁶

39
- 84921430469
- Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
- CD000953
- (2000) Cochrane Database Syst Rev , vol.1
- Pope, J.¹ Fenlon, D.² Thompson, A.³ Shea, B.⁴ Furst, D.⁵ Wells, G.⁶

40
- 0030859859
- The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon
- (1997) J Intern Med , vol.242 , pp. 373-376
- Pancera, P.¹ Sansone, S.² Secchi, S.³ Covi, G.⁴ Lechi, A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.